Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Amgen logoAmgen AMGN

The company said its stockholders approved the Second Amended and Restated 2009 Equity Incentive Plan at its annual meeting on May 31, 2024, and that the plan increases the number of shares of common stock available for issuance by 31,297,000 shares.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said its stockholders approved the Second Amended and Restated 2009 Equity Incentive Plan at its annual meeting on May 31, 2024, and that the plan increases the number of shares of common stock available for issuance by 31,297,000 shares.

  2. The company said the amended plan fully vests awards that are not assumed or replaced in a change of control, and the plan was approved with 377,156,504 votes for and 20,285,985 votes against.

  3. The company said all 12 director nominees were elected to one-year terms expiring at the 2025 annual meeting of stockholders, which is 1 year. The board assigned newly elected director Dr. Klotman to two committees effective June 1, 2024.

  4. The company said the advisory vote on executive compensation was approved with 372,548,836 votes for and 24,800,740 votes against, and Ernst & Young LLP was ratified as independent registered public accountants for the fiscal year ending December 31, 2024.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Stockholders Approve Amended and Restated Equity Incentive Plan in 2009

The company said its stockholders approved the Second Amended and Restated 2009 Equity Incentive Plan at its annual meeting on May 31, 2024, and that the plan increases the number of shares of common stock available for issuance by 31,297,000 shares.

Source · Based on the filing body and exhibits

Equity Incentive Plan Changes and Voting Results

The company said the amended plan fully vests awards that are not assumed or replaced in a change of control, and the plan was approved with 377,156,504 votes for and 20,285,985 votes against.

Source · Based on the filing body and exhibits

Election of 12 Directors and Klotman Committee Assignments

The company said all 12 director nominees were elected to one-year terms expiring at the 2025 annual meeting of stockholders, which is 1 year. The board assigned newly elected director Dr. Klotman to two committees effective June 1, 2024.

Source · Based on the filing body and exhibits

Executive Compensation Vote and Auditor Ratification

The company said the advisory vote on executive compensation was approved with 372,548,836 votes for and 24,800,740 votes against, and Ernst & Young LLP was ratified as independent registered public accountants for the fiscal year ending December 31, 2024.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.